Severe bronchospasm and acute respiratory failure associated with inhaled prostacyclin therapy

7 June 2024

Donna SteinbacherBrian MurrayThomas DevlinShannon S. CarsonH. James Ford

https://doi.org/10.1002/pul2.12396

Abstract

Prostacyclin therapy is a mainstay of the management of pulmonary arterial hypertension (PAH). Inhaled prostacyclins present safe and effective options for the management of PAH that limit systemic side effects. We describe the first reported case of life-threatening bronchospasm and acute respiratory failure associated with inhaled prostacyclin administration.

Read the full case report

Share:
Additional comments are available to members. Login or register to become a member today